Pseudovitelliform maculopathy secondary to BRAF and MEK inhibitors in a patient with metastasic melanoma

C Alba-Linero, C Rocha De Lossada, AS Delgado-Fernández, M Jódar-Márquez, M Rodríguez Calvo De Mora, MA Berciano-Guerrero

PDF(464 KB)
Journal of Biological Regulators and Homeostatic Agents ›› 2019, Vol. 33 ›› Issue (5) : 1497-1500. DOI: 10.23812/19-89-L
Letter

Pseudovitelliform maculopathy secondary to BRAF and MEK inhibitors in a patient with metastasic melanoma

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2019, 33(5): 1497-1500 https://doi.org/10.23812/19-89-L

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
Article Options
  • PDF (56 views)
  • Full Text ( views)

Accesses

Citation

Detail

Sections
Recommended

/